top of page
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute

Journal of Health and Medical Sciences

ISSN 2622-7258

Screen Shot 2018-08-12 at 1.24.09 AM.png
Screen Shot 2018-08-12 at 1.24.02 AM.png
Screen Shot 2018-08-12 at 1.23.57 AM.png
Screen Shot 2018-08-12 at 1.23.52 AM.png
open access

Published: 31 August 2022

Outcomes of COVID-19 in Children After Wide Distribution of COVID Vaccine, Albaha, Saudi Arabia

Abdulmajid Mustafa Almawazini, Ahmed Obaidalla Alghamdi, Ali Alsharkawy, Matar Ahmed Al Sehemi, Mohammed Ahmed Alghamdi, Njood Abdulaziz Alghamdi, Kholoud Mohammed Alghamdi, Lara Muaffak Alsakka, Nouf Abdullah Alghmadi, Hazem Almawazini, Mohammad Almawazini

KFH Albaha, Albaha University, Cairo University

journal of social and political sciences
pdf download

Download Full-Text Pdf



Pages: 52-55

Keywords: COVID-19, Children, Vaccine, Saudi Arabia


Background: The WHO announced COVID-19 as a pandemic on 12 March 2020, and has become a major public health around the world. Objectives: The study aimed to evaluate clinical presentation and outcomes of COVID-19 cases after wide distribution of COVID vaccine. Methods: Cross sectional study, retrospective file review of the children aged less than 14 years, and confirmed by positive swab test to have COVID 19, from May 2021 to May 2022. Results: A total of 125 patients with positive tests were included in this study. Males made up 52.8% (66/125) of the population, while females made up 47.2% (59/125). The age group of 5–10 years was the most affected, with 46.2%. The common symptoms noted were fever 90.4%, followed by abdominal pain 45.6%, vomiting 44%, diarrhea 41.6%, running nose 39.2%, cough 36%, and headache 25%. Conjunctivitis (4%) and skin rash (1.6%) were the least common symptoms. Only four patients needed PICU admission. No mortality was reported in this study. Conclusions: The study concluded that the COVID severity became less with a short hospital course after wide distribution of the COVID vaccine. Male patients were more affected than female patients in the age group 5-10 years. Severe cases were associated with comorbidities.


  1. World Health Organization (WHO). WHO characterizes COVID 19 as a pandemic [EB/OL], Geneva, Switzerland: World Health Organization, 2020. Available at: ttps://www. diseases/novel, coronavirus-2019/events as they happen, accessed on 6 Jan, 2021.

  2. R Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and Outcomes of Children with Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAM Pediatr, doi:10.1001/jamapediatrics.2020.1948. [PubMed].

  3. Sophia Tsabouri, MD, PhD. Ekaterini Siomou, MD, PhD. Risk Factors for Severity in Children with Coronavirus Disease 2019, A Comprehensive Literature Review. Published: July 30, 2020: https:// doi: 10.1016/j.pcl.2020.07.014. Review article, P321-338, Feb 01, 2021.

  4. Riccardo Castagnoli, MD; Martina Votto, MD; Amelia Licari, MD; Ilaria Brambilla, MD, PhD; Raffaele Bruno, MD; Stefano Perlini, MD; Francesca Rovida, PhD; Fausto Baldanti, MD; Gian Luigi Marseglia, MD. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents A Systematic Review.JAMA Pediatr. 2020; 174(9):882-889. Doi: 10.1001/jama pediatrics.2020.1467 published online April 22, 2020].

  5. Nallasamy K, Angurana SK, Jayashree M, Mathew JL, Bansal A, Singh MP et al. Clinical profile, hospital course and outcome of children with COVID-19. Indian J Pediatr. 2021;88(10):979-84. doi: 10.1007/s12098-020-03572.

  6. Zimmermann P, Curtis N. Coronavirus Infections in Children Including COVID-19. An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Pediatr Infect DisJ. 2020 May;39(5):355-368. doi: 10.1097/INF.0000000000002660.

  7. Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob, 2020 May 15;19(1):18. doi: 10.1186/s12941-020-00362-2.

  8. An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI) Updated guidance on a first booster dose of COVID-19 vaccines in Canada Published: April 12, 2022.

  9. Oliver J Watson, PhD, Gregory Barnsley, MSc, Jaspreet Toor, PhD, Alexandra B Hogan, PhD. Peter Winskill, PhD. Prof Azra C Ghani, PhD. Show footnotes. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Open Access Published: June 23, 2022. DOI:

  10. Abdullah A Algaissi, Naif Khalaf Alharbi, Mazen Hassanain, Anwar M.Hashem. Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience. J Infect Public Health, 2020 Jun;13(6):834-838. doi: 10.1016/j. jiph. 2020.04.016. Epub 2020 May 11.

  11. Shen KL, Yang YH, Jiang RM, Wang TY, Zhao DC, Jiang Y, et al. Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition). World J Pediatr, 2020 Jun;16(3):232-239. doi: 10.1007/s12519-020-00362-4.

  12. WMA Declaration of Helsinki, ethical principles for medical research involving human subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964 and amended by the: 29th WMA General Assembly, Tokyo, Japan, October 1975. 35th WMA General Assembly, Venice, Italy, October 1983. 41st WMA General Assembly, Hong Kong, September 1989. 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996. 52nd WMA General Assembly, Edinburgh, Scotland,October2000, 53rd WMA General Assembly, Washington DC, USA, October 2002 (Note of Clarification added). 55th WMA General Assembly, Tokyo, Japan, October 2004 (Note of Clarification added). 59th WMA General Assembly, Seoul, Republic of Korea, October, 2008 64th WMA General

  13. Assembly, Fortaleza, Brazil, October 2013.

  14. Almawazini, A., Alghamdi, A. O., Alnashi, S., Ahmed, M. S. A. S., Alsharkawy, A., Hassan, C. I., Alghamdi, M. A., Alshumrani, K. M., Yahiya, A., Jaman, M., Nakhali, A., Alghamdi, O., Alghamdi, E., Zahrani, M. Almawazini, H., Almawazini, M., Alshumrani, M., Ata, T. Madco, M., PayonGa, A., & Kundoly, T.Review of COVID-19 in Children Admitted to King Fahad Hospital, Albaha, Saudi Arabia in 2020, Journal of Health and Medical Sciences, Vol.5, No.1, 2022: 18-23. ISSN 2622-7258. DOI: 10.31014/aior.1994.05.01.203.

  15. Meena J, Yadav J, Saini L, Yadav A, Kumar J. Clinical Features and Outcome of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-analysis. Indian Pediatr. 2020 Sep 15;57(9):820-826. doi: 10.1007/s13312-020-1961-0. Epub 2020 Jun 24. PMID: 32583808; PMCID: PMC7498550.

  16. Ma X, Liu S, Chen L, Zhuang L, Zhang J, Xin Y. The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: a meta-analysis and systematic review. J Med Virol. J Med Virol. 2021;93(1):234-40. DOI: 10.1002/jmv.26208.

bottom of page